Thumbnail Image
Item

Efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy

Grisham, R.
; 
Aghajanian, C.
; 
Van Nieuwenhuysen, E.
; 
Rodrigues, M.
; 
Ring, K. R.
; 
Santin, A.
; 
Colombo, N.
; 
Prendergast, E.
; 
Thaker, P.
; 
Moore, K.
... show 10 more
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Grisham, R.
Aghajanian, C.
Van Nieuwenhuysen, E.
Rodrigues, M.
Ring, K. R.
Santin, A.
Colombo, N.
Prendergast, E.
Thaker, P.
Moore, K.
Salinas, E.
Ray-Coquard, I.
Chon, H. S.
Rose, P.
Oaknin, A.
Clamp, A.
Gandhi, M.
Monk, B.
Holloway, R.
Van Gorp, T.
Fabbro, M.
Gennigens, C.
Wojtynek, N.
Lustgarten, S.
Banerjee, S.
Affiliation
Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, New York, NY USA Leuven Canc Inst, Gynaecol & Obstet, Leuven, Belgium Inst Curie, Dept Med Oncol, Inserm U830, Paris, France Univ Virginia, Dept Obstet & Gynecol, Div Gynecol Oncol, Charlottesville, VA USA Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, New Haven, CT USA European Inst Oncol, Gynecol Oncol, Monza, Italy Minnesota Oncol, Gynecol Oncol, Minneapolis, MN USA Washington Univ, Sch Med, Div Gynecol Oncol, St Louis, MO USA Stephenson Canc Ctr, Gynecol Oncol, Oklahoma City, OK USA Compass Oncol, Gynecol Oncol, Portland, OR USA Ctr Leon Berard, Oncol, Lyon, France H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, AZ USA Cleveland Clin Fdn, Womens Hlth Inst, Cleveland, OH USA Vall dHebron Univ Hospitl, Oncol, Baracelona, Spain Christie NHS Fdn Trust, Manchester, Lancs, England Univ Manchester, Med Oncol, Manchester, Lancs, England Virginia Canc Specialists, Gainesville, VA USA Honorhealth Res Inst, Community Res Dev, Scottsdale, AZ USA Advent Hlth Canc Inst, Gynecol Oncol Program, Orlando, FL USA Univ Hosp Leuven, Leuven Canc Inst, Oncol, Leuven, Belgium ICM Val Aurelle Parc Euromed, Oncol Med, Gineco, Paris, France CHU Liege, Liege, Belgium Verastem Oncol, Med Affairs, Needham, MA USA Verastem Inc, Biostat, Needham, MA USA Royal Marsden NHS Fdn Trust, Natl Canc Res Inst NCRI, London, England Inst Canc Res, London, England
Description
Date
2023
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
Found from Unpaywall
Adobe PDF, 1.27 MB
Keywords
Type
Meetings and Proceedings
Citation
Grisham R, Aghajanian C, Van Nieuwenhuysen E, Rodrigues M, Ring KR, Santin A, et al. Efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023 NOV;33(SUPPL_4):A3-A4. PubMed PMID: WOS:001262421600035. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627685
Embedded videos